Congressional
Caucus
- Origins/Purpose
- Members
-
Briefings & Hearings
- Dec. 5, 2022: "Improving Diagnosis and Treatment Through Personalized Medicine"
- April 28, 2022: Promoting Innovation and Delivery of Cell and Gene Therapies
- Dec. 8, 2021: "The Future of Biomedicine: Translating Biomedical Research into Personalized Healthcare"
- June 30, 2020: "The Personalized Medicine Community's Response to COVID-19"
- February 26, 2020: "Technologies Advancing the Future of Personalized Medicine"
Congressional Caucus
The Congressional Personalized Medicine Caucus
June 30, 2020, Briefing
The Personalized Medicine Community's Response to COVID-19 (Virtual)
Featuring remarks from Congressional Personalized Medicine Caucus co-chairs Sen. Tim Scott (R-SC) and Rep. Eric Swalwell (D-CA) as well as updates from leaders in personalized medicine who were working to scale the United States’ diagnostic capacity and develop a vaccine at the height of the COVID-19 pandemic, The Personalized Medicine Community’s Response to COVID-19 convened a virtual audience of policymakers and health care thought leaders to underline the importance of bipartisan support for the personalized medicine community at an unprecedented moment in the history of the United States and the world.
» Video recording: The Personalized Medicine Community’s Response to COVID-19
» Video recording: The Personalized Medicine Community’s Response to COVID-19
June 30, 2020
"We are seeing that a one-size-fits-all approach is no better for COVID than it is for cancer, diabetes, Parkinson’s, Alzheimer’s, or any other illness.”
- Personalized Medicine Caucus Co-Chair Rep. Eric Swalwell during The Personalized Medicine Community’s Response to COVID-19